Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 244Leukemia, Myeloid, Acute 191Leukemia 145Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Precursor Cell Lymphoblastic Leukemia-Lymphoma 120Myeloproliferative Disorders 89Multiple Myeloma 84Leukemia, Lymphocytic, Chronic, B-Cell 78Lymphoma, Non-Hodgkin 76Primary Myelofibrosis 72Leukemia, Myelomonocytic, Chronic 69Lymphoma 67Hodgkin Disease 66Leukemia, Myeloid, Chronic-Phase 55Lymphoma, Mantle-Cell 50Blast Crisis 49Lymphoma, Large B-Cell, Diffuse 47Lymphoma, Follicular 44Leukemia, Myeloid, Accelerated Phase 44Congenital Abnormalities 41Lymphoma, B-Cell, Marginal Zone 40Burkitt Lymphoma 40Neoplasms, Plasma Cell 38Lymphoma, Large-Cell, Immunoblastic 35Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 35Polycythemia Vera 32Hematologic Neoplasms 31Myelodysplastic-Myeloproliferative Diseases 30Lymphoma, T-Cell, Cutaneous 29Anemia, Refractory, with Excess of Blasts 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Adenoviridae Infections × Myeloid × Clear all
NCT02231853 2019-12-17

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
12 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Adenoviridae Infections, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡